Remove Bacterium Remove Protein Remove Scientist
article thumbnail

The Pharma Data - Untitled Article

The Pharma Data

Years of toil in the laboratory have revealed how a marine bacterium makes a potent anti-cancer molecule. Scientists now for the first time understand the enzyme-driven process that activates the molecule. The marine bacterium involved, called Salinispora tropica, makes salinosporamide to avoid being eaten by its predators.

article thumbnail

Scientists discover small RNA that regulates bacterial infection

The Pharma Data

Scientists discover small RNA that regulates bacterial infection People with weakened immune systems are at constant risk of infection. The mRNAs encode the proteins that do all the work in a cell, so by measuring a bacterium’s mRNA level, one can infer the bacterium’s behavior.

RNA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Research Shows IBS Symptoms May be Caused by Gut Infections

XTalks

Through laboratory and clinical studies, the scientists discovered that blockade of histamine could help alleviate IBS symptoms. The mice were fed the protein again after the infection had been cleared, to see whether the infection had sensitized the immune system.

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

Johnson & Johnson’s Top 5 Best-Selling Drugs of 2022: 1) Stelara (ustekinumab) Stelara is an immunosuppressant biologic therapy that blocks the IL-12 and IL-23 proteins that play a role in plaque psoriasis and Crohn’s disease. The monoclonal antibody targets CD20, a protein found on the surface of B lymphocytes (B cells).

Sales 98
article thumbnail

2020 Year in Review: COVID-19, CRISPR and Immunotherapies Define the Year for the Life Sciences

XTalks

After being identified in December 2019 in Wuhan, Hubei in China, medical officials and scientists got to work to isolate and identify the novel virus that they observed to be causing a new respiratory illness. Most antibody drugs and vaccines have been developed to target parts of the spike protein.